Showing results (1-10 of 308) with videos related to
Sort By:
Pageof 31
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1990
Immunologic effects of interleukin-2 adoptive immunotherapy in humans: acute in vitro anergy, in vivo antibody response to tetanusE W Ades, D Bosse, S Orr, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1990
Immune responses in humans while receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells: acute anergy to mitogens and recall antigensE W Ades, D Bosse, S Orr, et al.Journal of Immunopharmacology|January 1, 1986
Protective effect(s) of rIL-2 modulation. I. The effects of chemotherapeutic/cytotoxic agents on human natural killer cells and lymphokine-activated killer cellsE W Ades, A HinsonJournal of Clinical & Laboratory Immunology|August 1, 1983
Effector cell sensitivity to sugar moieties. II. Inhibition by monosaccharides of interferon enhanced human natural killingE W Ades, A HinsonJournal of Clinical & Laboratory Immunology|July 1, 1989
Immunotherapy and enhanced antibody-dependent cell-mediated cytotoxicity using virally-infected target cellsD Bosse, E W AdesJournal of Clinical Microbiology|February 1, 1990
Growth of Vero E-6 cells on microcarriers in a cell bioreactorL A White, E W AdesClinical Immunology and Immunopathology|April 1, 1984
Prospective study of natural cytotoxicity in peripheral blood of patients with nonlymphoid solid malignanciesL D Stewart, E W AdesJournal of Clinical & Laboratory Immunology|April 1, 1983
Human natural killer cells: correlation of a lytic assay with a visual binding assayL D Stewart, E W AdesClinical Immunology and Immunopathology|January 1, 1988
Lymphokine-activated killer cell lysis of human neuroblastoma cells: a model for purging tumor cells from bone marrowE W Ades, N Peacocke, H SabioJournal of Clinical & Laboratory Immunology|February 1, 1986
Effector cell sensitivity to sugar moieties. III. Inhibition by monosaccharides of interleukin-2 enhanced natural killing against viral and nonviral tumor target cellsE W Ades, A Hinson, M CulwellPageof 31